Claims for Patent: 6,130,208

Summary for Patent: 6,130,208

Title:	Formulation containing a nucleotide analogue
Abstract:	A pharmaceutical composition comprising a nucleotide analogue and one or more glass forming additives which is suitable for freeze drying.
Inventor(s):	Broadhead; Joanne (Loughborough, GB)
Assignee:	AstraZeneca UK Limited (London, GB)
Application Number:	09/125,165
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,130,208
Patent Claims:	1. A pharmaceutical composition comprising a nucleotide analog and one or more glass forming additives, wherein the nucleotide is a compound of formula (I): ##STR6## wherein R.sup.1 and R.sup.2 independently represent hydrogen or halogen, R.sup.3 and R.sup.4 independently represent phenyl, or C.sub.1-6 -alkyl optionally substituted by one or more substituents selected from OR.sup.5, C.sub.1-6 -alkylthio, NR.sup.6 R.sup.7, phenyl, COOR.sup.8 and halogen, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 independent represent hydrogen or C.sub.1-6 -alkyl and X represents an acidic moiety, or a pharmaceutically acceptable salt thereof. 2. A pharmaceutical composition according to claim 1 which is in freeze-dried, spray dried or vacuum dried form. 3. A pharmaceutical composition according to claim 1 which is in reconstituted form. 4. A pharmaceutical composition according to claim 1 and further including a modifying agent. 5. A pharmaceutical composition according to claim 4, in which the modifying agent is sucrose. 6. A method of treating a platelet aggregation disorder which method comprises treating a subject suffering from a said disorder with a therapeutically effective amount of a pharmaceutical composition as defined in claim 1. 7. A process for the preparation of a pharmaceutical composition according to claim 2 which process comprises mixing the ingredients of the composition, and either freezing them and drying the frozen mixture, or spray-drying them. 8. A method of treating acute coronary syndromes and percutaneous transluminal coronary angioplasty in a patient in need of said treatment, said method comprising the step of administering to said patient a therapeutically effective amount of a pharmaceutical composition as defined in claim 1. 9. A method of treating angina in a patient in need of said treatment, said method comprising the step of administering to said patient a therapeutically effective amount of a pharmaceutical composition as defined in claim 1.